Quanterix Corporation (QTRX) Decreased to All-Time Low

June 29, 2018 - By Georgina Andrews

On Jun, 29, all time low was touched by Quanterix Corporation (NASDAQ:QTRX). Today’s share price was $13.95. It’s 4.00 % below our $13.39. Barchart.com reported this technical pattern. Quanterix Corporation (NASDAQ:QTRX) has $306.34 million MC. At $13.39 stock target, the company valuation changes by $12.25 million less.

QTRX hit $13.95 during the last trading session after $0.13 change.Quanterix Corporation has volume of 46,443 shares. Since June 29, 2017 QTRX has 0.00% and is . The stock underperformed the S&P500 by 12.57%.

Investors wait Quanterix Corporation (NASDAQ:QTRX)’s quarterly earnings on August, 21., as reported by Faxor. Analysts at Wall Street see Quanterix Corporation’s -15.15 % EPS growth compared to $-0.33 earnings per share for previous quarter.

For more Quanterix Corporation (NASDAQ:QTRX) news released briefly go to: Businesswire.com, Benzinga.com, Businesswire.com, Benzinga.com or Benzinga.com. The titles are as follows: “Hercules Capital on Pace to Potentially Exceed $1.0 Billion in Total New Debt and Equity Commitments in 2018” released on June 11, 2018, “45 Biggest Movers From Yesterday” on June 06, 2018, “EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of …” with a publish date: June 13, 2018, “35 Stocks Moving In Tuesday’s Mid-Day Session” and the last “The Week Ahead: Apple’s Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs” with publication date: June 04, 2018.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific.The firm is valued at $306.34 million. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.Currently it has negative earnings. The company's products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips.

Quanterix Corporation (NASDAQ:QTRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: